Update from GOV.UK for: Mirdametinib approved to treat plexiform neurofibromas in children, adolescents, and adults with neurofibromatosis type 1
Update from GOV.UK for: News and communications Mirdametinib approved to treat plexiform neurofibromas in children, adolescents, and adults with neurofibromatosis type 1 Page summary: As with any medicine, the MHRA will keep the safety and effectiveness o…  | GOV.UK | | |
|
| Update from GOV.UK for: News and communications
Page summary:
As with any medicine, the MHRA will keep the safety and effectiveness of mirdametinib under close review. Change made:
First published. Time updated:
2:29pm, 11 December 2025
Why am I getting this email?You asked GOV.UK to send you an email each time we add or update a page about: News and communications Unsubscribe Change your email preferences |
|
|
Kaffi's
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
No comments:
Post a Comment